Synergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: New insights into ascorbate cytotoxicity.
about
Vitamin C Transporters in Cancer: Current Understanding and Gaps in Knowledge.Pharmacologic ascorbate (P-AscH-) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma.Intravenous Vitamin C for Cancer Therapy - Identifying the Current Gaps in Our KnowledgePalladium concave nanocrystals with high-index facets accelerate ascorbate oxidation in cancer treatment
P2860
Synergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: New insights into ascorbate cytotoxicity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Synergistic effects of ascorba ...... s into ascorbate cytotoxicity.
@en
type
label
Synergistic effects of ascorba ...... s into ascorbate cytotoxicity.
@en
prefLabel
Synergistic effects of ascorba ...... s into ascorbate cytotoxicity.
@en
P2093
P2860
P1476
Synergistic effects of ascorba ...... s into ascorbate cytotoxicity.
@en
P2093
Anil Noronha Antony
Cataldo Doria
Daniel A Monti
Jan B Hoek
Lauren Rouleau
Mark Levine
Sara Bisetto
P2860
P304
P356
10.1016/J.FREERADBIOMED.2016.03.031
P577
2016-03-30T00:00:00Z